Industry · the U.S. · October 13, 2026
From CNBC Top News
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
Reported by CNBC Top News, October 13, 2026. Read the full story at CNBC Top News →